Covid-19 Alert: if you have cold or flu-like symptoms (fever, cough, difficulty breathing, body aches, or chills, headache, sore throat, or loss of taste or smell), you must call us at 515.282.2921 before coming into Mission Cancer + Blood, even if you have an appointment. Tell us about your symptoms before coming in – Thank you!

RENAL CELL CARCINOMA AREN1721

Study #AREN1721

TFE/tRCC: A Randomized Phase II Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Axitinib or Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups

Back To Clinical Trials